The current procedure for treatment of uveal melanoma with proton therapy involves a pre-treatment surgical intervention. This creates a paradoxical situation, in which the non-invasive tumor treatment via proton therapy requires invasive surgical preparation of patient’s eye. Utilization of modern imaging methods and optical tracking systems opens up a possibility to create completely non-invasive workflow.
The aim of this project is to implement and benchmark the non-invasive workflow based on optical tracking and multi-modality imaging techniques.
Through the novel workflow, one could achieve complete non-invasiveness in ocular proton therapy, thus sparing the patient of the pre-treatment surgical procedure and non-curative radiographic imaging dose, while potentially further improving treatment personalization.
During the pre-treatment surgery, there are small clips sutured on the sclera in the proximity of tumor lesion. The clips serve as a surrogate of a tumor and play a key role in preparation of a patient specific geometric model of the eye and the tumor used for optimization of proton therapy. Clips are further utilized prior to proton therapy, to ensure the accurate alignment of the tumor in relation to the treatment beam (through x-ray imaging of the clips). Modern imaging methods open up a possibility to create a geometrically accurate model representation of an eye and tumor. Optical tracking systems carry a potential to align treated eye to treatment beam without clips and the associated x-ray imaging.
Patents / Startups
Eye Tracking in Ocular Proton Therapy, 2020, Via R, Fattori G, Pica A, Baroni G, Lomax A, Weber DC, Hrbacek J, Proceedings of ACM Symposium on Eye Tracking Research & Application, https://doi.org/10.1145/3379157.3391991
MRI and fundus image fusion for improved ocular biometry in ocular proton therapy, 2022, Via R, Pica A, Antonioli L, Paganelli C, Fattori G, Spaccapanicca C, Lomax A, Weber DC, Schalenbourg A, Baroni G, Hrbacek J, https://doi.org/10.1016/j.radonc.2022.06.021
Non-invasive recognition of eye torsion through optical imaging of the iris pattern in ocular proton therapy, 2021, Spaccapaniccia C, Via R, Thominet V, Liffey A, Baroni G, Pica A, Weber DC, John Lomax A, Hrbacek J, https://doi.org/10.1088/1361-6560/ac0afb
Potential and pitfalls of 1.5 T MRI imaging for target volume definition in ocular proton therapy, 2021, Via R, Hennings F, Pica A, Fattori G, Beer J, Peroni M, Baroni G, Lomax A, Weber DC, Hrbacek J, Radiotherapy and Oncology, https://doi.org/10.1016/j.radonc.2020.08.023
Patents / Startups
Dr. Jan Hrbacek
Center for Proton Therapy, Paul Scherrer Institute